Skip to main content
Premium Trial:

Request an Annual Quote

New Horizons in Silicon Valley

Things must be going well for Affymax, biopharma and birthplace of Affymetrix. The company, which had its IPO recently and has entered clinical trials with its lead candidate, just expanded its office space by more than 30,000 square feet -- that's an increase of over 50 percent from its prior space -- according to this article in the Silicon Valley / San Jose Business Journal.


The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.